These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 12023792)
1. Pemetrexed in patients with gastrointestinal carcinoma. de Gramont A; Kindler HL Semin Oncol; 2002 Apr; 29(2 Suppl 5):42-9. PubMed ID: 12023792 [TBL] [Abstract][Full Text] [Related]
2. The potential role of pemetrexed in gastrointestinal cancer. Meriggi F; Di Biasi B; Caliolo C; Zaniboni A Chemotherapy; 2008; 54(1):1-8. PubMed ID: 18063861 [TBL] [Abstract][Full Text] [Related]
3. The role of pemetrexed in the treatment of colorectal cancer. Hochster H Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812 [TBL] [Abstract][Full Text] [Related]
5. Phase I trials of pemetrexed. Fossella FV; Gatzemeier U Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787 [TBL] [Abstract][Full Text] [Related]
6. Pemetrexed: a promising new treatment for breast cancer. O'Shaughnessy JA; Gennari A; Conte P Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791 [TBL] [Abstract][Full Text] [Related]
7. Pemetrexed in the treatment of selected solid tumors. Adjei AA Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793 [TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in the treatment of non-small cell lung cancer. Shepherd FA Semin Oncol; 2002 Dec; 29(6 Suppl 18):43-8. PubMed ID: 12571810 [TBL] [Abstract][Full Text] [Related]
9. The role of pemetrexed in the treatment of gastrointestinal malignancy. Hochster HS Clin Colorectal Cancer; 2004 Sep; 4(3):190-5. PubMed ID: 15377402 [TBL] [Abstract][Full Text] [Related]
13. Pemetrexed in bladder, head and neck, and cervical cancers. Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815 [TBL] [Abstract][Full Text] [Related]
14. Pemetrexed: an active new agent for breast cancer. O'Shaughnessy JA Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813 [TBL] [Abstract][Full Text] [Related]
15. Pemetrexed in advanced colorectal cancer. Louvet C; de Gramont A Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):56-62. PubMed ID: 15655939 [TBL] [Abstract][Full Text] [Related]
16. Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer. Scagliotti GV Lung Cancer; 2005 Oct; 50 Suppl 1():S18-9. PubMed ID: 16291426 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer. Le Chevalier T Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960 [TBL] [Abstract][Full Text] [Related]
18. Pemetrexed combination therapy in the treatment of non-small cell lung cancer. Rosell R; Crinó L Semin Oncol; 2002 Apr; 29(2 Suppl 5):23-9. PubMed ID: 12023789 [TBL] [Abstract][Full Text] [Related]
19. Further study on pemetrexed based chemotherapy in treating patients with advanced gastric cancer (AGC). Liu J; Huang XE; Feng JF Asian Pac J Cancer Prev; 2014; 15(16):6587-90. PubMed ID: 25169492 [TBL] [Abstract][Full Text] [Related]
20. A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer. Wu XY; Huang XE; Cao J; Shi L; Xu X; Qian ZY Asian Pac J Cancer Prev; 2014; 15(14):5941-4. PubMed ID: 25081726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]